CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia by Ying-Ping Jiang, Bob Y. Liu, Quan Zheng, Swapna Panuganti, Ruoying Chen, Jianyu Zhu, Madhavi Mishra, Jianqing Huang, Trang Dao-Pick, Sharmili Roy, XiaoXian Zhao, Jeffrey Lin, Gautam Banik, Eric D. Hsi, Ramkumar Mandalam, Jagath R. Junutula

Get full text

265 ADI-925: an allogeneic off-the-shelf chimeric adapter (CAd) γδ T cell therapy targeting NKG2D ligand-expressing cancers by Xue Yang, Marissa Herrman, Jonathan Wong, Ramandeep Kaur, Taylor Barca, Kevin P Nishimoto, Maryam Tabrizizad, Arun Bhat, Blake T Aftab, Morgan Smith-Boeck, Louise Kiru, Kyle McSweeney, Amy Doan, Kimberly Rodriquez, Smitha Rao Yelaguli Gundurao, Ngoc T Hoang, Hayden Tessman, Taylor Wingfield, Philip A Storm, Christopher J Rold, Swapna Panuganti

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models by Kevin P Nishimoto, Taylor Barca, Aruna Azameera, Amani Makkouk, Jason M Romero, Lu Bai, Mary M Brodey, Jackie Kennedy‐Wilde, Hui Shao, Stephanie Papaioannou, Amy Doan, Cynthia Masri, Ngoc T Hoang, Hayden Tessman, Vidhya Dhevi Ramanathan, Ana Giner‐Rubio, Frank Delfino, Kriti Sharma, Kevin Bray, Matthew Hoopes, Daulet Satpayev, Ranjita Sengupta, Marissa Herrman, Stewart E Abbot, Blake T Aftab, Zili An, Swapna Panuganti, Sandra M Hayes

Get full text